knowledge -WSS

knowledge

author：leisure time 2025-10-02 23:30:30 - browse：52

the U.S. Medicare Handbook is photographed in Washington. — Pablo Martinez Monsivais/AP

Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Readout LOUD podcast: What to know about H5N1 bird flu

hotspot

WSS

The problem with charging patients to message their doctors

Telehealth startups turn to complex chronic diseases

The drug industry has found itself all alone in Washington

Bird flu outbreak in cows is latest avian flu curveball

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

First medicine developed to treat MASH expected to be approved soon

leisure time

knowledge

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Google says AlphaFold 3 can map a vast universe of biomolecules

As demand for Covid shots wanes, Moderna seeks its next success

Telehealth startups turn to complex chronic diseases

As demand for Covid shots wanes, Moderna seeks its next success

Making AI in medicine accessible to smaller, and rural hospitals

How one medical school became remarkably diverse

Just how do doctors, lawmakers, and the public define abortion?

What does generative AI mean for health care? We asked experts

Novo Nordisk obesity pill bests Wegovy in early trial

knowledge

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

First medicine developed to treat MASH expected to be approved soon

Medicare says breakthrough device reimbursement rule to come by summer

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Researchers on aging grapple with how to calculate biological age

hotspot

knowledge

focus

leisure time